Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE0007165607
Tue, 02.07.2024
SARTORIUS AG
Disclosure of inside information according to Article 17 MAR
Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office
The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the company's Supervisory Board that, after more than 20 years as CEO, he will not be seeking another contr [ … ]
Wed, 07.02.2024
SARTORIUS AG
Disclosure of an inside information according to Article 17 of the Regulation (EU) No 596/2014 (MAR)
Not to be released, published, distributed or circulated in South Africa, Canada, Australia, Japan or any other jurisdiction in which it would be unlawful to do so. This notification is not a prospectus within the meaning of Regulation (EU) 2017/11 [ … ]
Tue, 06.02.2024
SARTORIUS AG
Disclosure of an inside information according to Article 17 of the Regulation (EU) No 596/2014 (MAR)
Not to be released, published, distributed or circulated in South Africa, Canada, Australia, Japan or any other jurisdiction in which it would be unlawful to do so. This notification is not a prospectus within the meaning of Regulation (EU) 2017/11 [ … ]
Thu, 12.10.2023
SARTORIUS AG
Disclosure of inside information according to Article 17 MAR
Sartorius pre-announces preliminary 9-month results and lowers forecast for 2023
According to preliminary figures, the life science group Sartorius recorded consolidated sales revenue of around 2,546 million euros in the first nine months of 2023, which corresponds to a decline of aroun [ … ]
Thu, 12.10.2023
SARTORIUS AG
Disclosure of inside information according to Article 17 MAR
Sartorius pre-announces preliminary 9-month results and lowers forecast for 2023
According to preliminary figures, the life science group Sartorius recorded consolidated sales revenue of around 2,546 million euros in the first nine months of 2023, which corresponds to a decline of aroun [ … ]
Fri, 16.06.2023
SARTORIUS AG
Disclosure of inside information according to Article 17 MAR
Sartorius lowers forecast for 2023
Based on continuing general weak demand dynamics, Sartorius expects sales revenue to develop below expectations in the second half of the year and thus adapts its guidance for both divisions as well as for the Group for fiscal 2023. The main facto [ … ]
Fri, 16.06.2023
SARTORIUS AG
Disclosure of inside information according to Article 17 MAR
Sartorius lowers forecast for 2023
Based on continuing general weak demand dynamics, Sartorius expects sales revenue to develop below expectations in the second half of the year and thus adapts its guidance for both divisions as well as for the Group for fiscal 2023. The main facto [ … ]
Mon, 05.07.2021
SARTORIUS AG
Disclosure of inside information according to Article 17 MAR
Sartorius provides preliminary first-half financial key figures and raises forecast for 2021
Sartorius announces today that it expects strong first-half performance and raises its forecast for the full year of 2021. For the first six months ended June 30, the company expects revenue gro [ … ]